Evidence map›Paper›PMID 24129178›Full record

ArticleInternational journal of molecular sciences2013

Inhibition of melanogenesis by gallic acid: possible involvement of the PI3K/Akt, MEK/ERK and Wnt/β-catenin signaling pathways in B16F10 cells.

Tzu-Rong Su, Jen-Jie Lin, Chi-Chu Tsai, Tsu-Kei Huang, Zih-Yan Yang, Ming-O Wu, Yu-Qing Zheng, Ching-Chyuan Su, Yu-Jen Wu

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed
4.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 155 citations in OpenAlex.

  1. Article
  2. Article
  3. Skin-Whitening, Antiwrinkle, and Moisturizing Effects ofInternational journal of molecular sciences · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Effect of bioactive compounds ofIn silico pharmacology · 2024
    Article
  15. Review
  16. Article
  17. Two High-QualityInternational journal of molecular sciences · 2023
    Article
  18. Article
  19. Article
  20. FermentedMolecules (Basel, Switzerland) · 2023
    Article

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Tzu-Rong SuAntai Medical Care Cooperation Antai Tian-Sheng Memorial Hospital, Pingtung 92842, Taiwan. x00002180@meiho.edu.tw.
Jen-Jie Lin
Chi-Chu Tsai
Tsu-Kei Huang
Zih-Yan Yang
Ming-O Wu
Yu-Qing Zheng
Ching-Chyuan Su
Yu-Jen Wu
Chang Gung Memorial Hospital · TWMeiho University · TWNational Pingtung University of Science and Technology · TWPingtung Hospital · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gallic acid is one of the major flavonoids found in plants. It acts as an antioxidant, and seems to have anti-inflammatory, anti-viral, and anti-cancer properties. In this study, we investigated the effects of gallic acid on melanogenesis, including the activation of melanogenesis signaling pathways. Gallic acid significantly inhibited both melanin synthesis and tyrosinase activity in a dose- and time-dependent manner, and decreased the expression of melanogenesis-related proteins, such as microphthalmia-associated transcription factor (MITF), tyrosinase, tyrosinase-related protein-1 (TRP1), and dopachrome tautomerase (Dct). In addition, gallic acid also acts by phosphorylating and activating melanogenesis inhibitory proteins such as Akt and mitogen-activated protein kinase (MEK)/extracellular signal-regulated kinase (ERK). Using inhibitors against PI3K/Akt (LY294002) or MEK/ERK-specific (PD98059), the hypopigmentation effect was suppressed, and the gallic acid-initiated activation of MEK/ERK and PI3K/Akt was also revoked. Gallic acid also increased GSK3β and p-β-catenin expression but down-regulated p-GSK3β. Moreover, GSK3β-specific inhibitor (SB216763) restored gallic acid-induced melanin reduction. These results suggest that activation of the MEK/ERK, PI3K/Akt, and inhibition of Wnt/β-catenin signaling pathways is involved in the melanogenesis signaling cascade, and that activation by gallic acid reduces melanin synthesis via down-regulation of MITF and its downstream signaling pathway. In conclusion, gallic acid may be a potentially agent for the treatment of certain skin conditions.

Indexed as

Animalsbeta CateninCell Line, TumorDown-RegulationGallic AcidIntramolecular OxidoreductasesMAP Kinase Signaling SystemMelaninsMelanoma, ExperimentalMiceMicrophthalmia-Associated Transcription FactorMonophenol MonooxygenaseOxidoreductasesPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktSignal Transductionbeta Catenindopachrome isomeraseGallic AcidIntramolecular OxidoreductasesMelaninsMicrophthalmia-Associated Transcription FactorMitf protein, mouseMonophenol MonooxygenaseOxidoreductasesPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-akttyrosinase-related protein-1Wnt Proteins

Identifiers

PMID24129178
PMCPMC3821624
OpenAlexW1968873637

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.